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Firing activity of serotonin (5-HT) neurons in the dorsal raphe nucleus (DRN) is controlled
by inhibitory somatodendritic 5-HT1A autoreceptors. This autoinhibitory mechanism is
implicated in the etiology of disorders of emotion regulation, such as anxiety disorders
and depression, as well as in the mechanism of antidepressant action. Here, we
investigated how persistent alterations in brain 5-HT availability affect autoinhibition in two
genetically modiﬁedmousemodels lacking critical mediators of serotonergic transmission:
5-HT transporter knockout (Sert−/−) and tryptophan hydroxylase-2 knockout (Tph2−/−)
mice. The degree of autoinhibition was assessed by loose-seal cell-attached recording
in DRN slices. First, application of the 5-HT1A-selective agonist R(+)-8-hydroxy-2-(di-
n-propylamino)tetralin showed mild sensitization and marked desensitization of 5-HT1A
receptors in Tph2−/− mice and Sert−/− mice, respectively. While 5-HT neurons from
Tph2−/− mice did not display autoinhibition in response to L-tryptophan, autoinhibition
of these neurons was unaltered in Sert−/− mice despite marked desensitization of their
5-HT1A autoreceptors. When the Tph2-dependent 5-HT synthesis step was bypassed by
application of 5-hydroxy-L-tryptophan (5-HTP), neurons from both Tph2−/− and Sert−/−
mice decreased their ﬁring rates at signiﬁcantly lower concentrations of 5-HTP compared
to wildtype controls. Our ﬁndings demonstrate that, as opposed to the prevalent view,
sensitivity of somatodendritic 5-HT1A receptors does not predict the magnitude of 5-HT
neuron autoinhibition. Changes in 5-HT1A receptor sensitivity may rather be seen as an
adaptive mechanism to keep autoinhibition functioning in response to extremely altered
levels of extracellular 5-HT resulting from targeted inactivation of mediators of serotonergic
signaling.
Keywords: serotonin transporter, tryptophan hydroxylase-2, knockout, dorsal raphe nucleus, autoinhibition,
5-HT1A receptor
INTRODUCTION
The brain serotonin (5-HT) system has been implicated in emo-
tion regulation and related psychopathological states, including
anxiety, depression, impulsivity, and aggression (reviewed in
Lesch et al., 2012). The 5-HT system originates from speciﬁed
neurons located in distinct nuclei of the brainstem raphe com-
plex. Among them, the dorsal raphe nucleus (DRN) contains the
majority of 5-HT neurons and sends projections to various tar-
gets in the forebrain. 5-HT neurons in the DRN are known to
exhibit spontaneous regular ﬁring activities (Trulson and Jacobs,
1979; Vandermaelen and Aghajanian, 1983). The ﬁring rate of 5-
HT neurons is a determinant of 5-HT concentration and thus
Abbreviations: DRN, dorsal raphe nucleus; 5-HT, serotonin; 5-HTP, 5-hydroxy-
L-tryptophan; R(+)-8-OH-DPAT, R(+)-8-hydroxy-2-(di-n-propylamino)tetralin;
Sert, serotonin transporter; Tph2, tryptophan hydroxylase-2; Trp, L-tryptophan.
function in terminal regions, together with local mechanisms
(Jacobs and Azmitia, 1992). In waking states, ﬁring of 5-HT
neurons is facilitated by noradrenergic input (Levine and Jacobs,
1992). Activity of 5-HT neurons is, in turn, limited by home-
ostatic negative feedback control exerted by extracellular 5-HT
via somatodendritic inhibitory 5-HT1A autoreceptors (Audero
et al., 2008 and references therein). The role of 5-HT1A recep-
tors in suppression/regulation of 5-HT neuron ﬁring activity is
considered to be relevant to the pathophysiology of disorders of
emotion regulation (Pineyro and Blier, 1999; Sharp et al., 2007).
The importance of 5-HT1A receptor function is further sup-
ported by the presumed mechanism of selective 5-HT reuptake
inhibitor (SSRI) antidepressant action (Artigas et al.,1996; Pineyro
and Blier, 1999). After acute administration of SSRI, extracellu-
lar 5-HT concentrations transiently increase and activate 5-HT1A
autoreceptors, inhibiting ﬁring of 5-HT neurons. One criterion
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of antidepressants’ therapeutic effects is desensitization of these
5-HT1A receptors, leading to a net increase of 5-HT levels. In
this context, dysfunction of autoinhibitory 5-HT1A receptors has
been proposed as a potential factor contributing to the pathogen-
esis of emotional disorders. However, studies on 5-HT1A receptor
expression in the raphe nuclei of patients with depression mea-
sured in vivo using positron emission tomography (PET) or in
post-mortem brains have yielded contradictory ﬁndings: some
investigators reported decreased expression (Drevets et al., 1999;
Sargent et al., 2000; Arango et al., 2001; Meltzer et al., 2004), while
others found enhanced expression (Stockmeier et al., 1998) or no
difference compared to controls (Parsey et al., 2006). Moreover,
PET imaging data revealed reduced 5-HT1A binding in several
brain regions including the raphe complex in panic disorder
patients either with or without comorbid depression (Neumeis-
ter et al., 2004). To date, most studies concentrated on associations
between expression levels of 5-HT1A receptors with depressive dis-
orders and there has been no direct evidence demonstrating how
altered 5-HT1A receptor availability translates into the extent of
5-HT neuron autoinhibition. The discrepancies among reports
describing a relationship between 5-HT1A receptor expression
and depression indicate a need for better understanding of the
precise mechanisms linking autoinhibition to 5-HT1A receptor
function.
Among various mediators of the brain 5-HT signaling, the
5-HT transporter (SERT, 5-HTT, SLC6A4) plays a central role
because (i) it mediates the re-uptake of 5-HT from the extracellu-
lar space/synapse and thus terminates the 5-HT signaling and (ii) it
is the target of numerous antidepressant drugs which inhibit its
action. Carriers of the short variant (s-allele) of the transcriptional
control region of the gene encoding SERT (5-HTT gene-linked
polymorphic region, 5-HTTLPR),which leads to lower expression
and thus a lower amount of SERT protein, are known to convey
increased risk for emotional disorders in interaction with envi-
ronmental factors (reviewed in Canli and Lesch, 2007). On the
other hand, tryptophan hydroxylase (TPH) is the rate-limiting
enzyme of 5-HT synthesis by converting the essential amino acid
L-tryptophan (Trp) into 5-hydroxy-L-tryptophan (5-HTP). 5-
HTP is then transformed into 5-HT by aromatic L-amino acid
decarboxylase (AADC; Carlsson et al., 1972). While the ﬁrst iso-
form TPH1 produces 5-HT in peripheral tissues and the pineal
gland, the recently discovered TPH2 isoform is responsible for 5-
HT synthesis in the brain (Gutknecht et al., 2009). Variation of the
gene coding for TPH2 has been associated with personality traits
related to emotional regulation (Gutknecht et al., 2007). More-
over, several polymorphisms in TPH2, which had previously been
linked to mood disorders, were shown to lead to reduced expres-
sion of TPH2 (reviewed in Jacobsen et al., 2012a). Contribution
of 5-HT to the regulation of emotion has been further veriﬁed
by studies on mice with targeted inactivation of either Sert or
Tph2. Indeed, Sert knockout (−/−) mice have been shown to dis-
play anxiety- and depression-like behaviors (reviewed in Murphy
and Lesch, 2008). Tph2−/− mice have also been reported to have
altered behaviors such as increased conditioned fear responses,
aggression, depression-like behaviors, and impairment of mater-
nal care (Savelieva et al., 2008; Alenina et al., 2009; Mosienko et al.,
2012; for review, see Lesch et al., 2012).
Here, we investigated ﬁring activity of DRN 5-HT neurons
in brain slices obtained from Sert−/− mice and Tph2−/− mice
using loose-seal cell-attached recording conﬁguration. Compared
to wildtype (wt) controls, Sert−/− mice were shown to have
∼6- to 10-fold elevated extracellular 5-HT concentrations at
baseline in several brain regions including the striatum and the
frontal cortex, while heterozygous Sert+/− mice were shown
to have milder increase, e.g., ∼3-fold in the striatum (Fabre
et al., 2000; Mathews et al., 2004; Shen et al., 2004). In contrast,
Tph2−/− mice were reported to display an almost complete
depletion of brain 5-HT, while Tph2+/− mice showed lower
reduction in brain 5-HT, reaching 20–25% in the rostral raphe
(Gutknecht et al., 2012). Both knockout mice therefore provide
useful models to investigate potential modulation of autoinhibi-
tion of 5-HT neuron ﬁring as a function of varying degrees of
5-HT availability in the cellular environment. Moreover, since
both mouse lines have extensively been investigated as models for
emotional disorders, investigating 5-HT neuron autoinhibitory
functions in these mice will facilitate detection of potential
alterations in autoinhibition related to disorders of emotion
regulation.
In order to mimic in vivo 5-HT synthesis in in vitro experimen-
tal conditions, we applied 5-HTprecursors through superfusion of
brain slices under recording. Prior to this, we assessed the function
of autoinhibitory 5-HT1A receptors by applying their direct ago-
nist. Feasibility of assessing autoinhibition in in vitro conditions
had been established in previous studies (Liu et al., 2005; Mlinar
et al., 2005; Evans et al., 2008; Gutknecht et al., 2012).
MATERIALS AND METHODS
ANIMALS
Animal handling followed the European Community guidelines
for animal care (DL 116/92, application of the European Com-
munities Council Directive 86/609/EEC) and approved by the
local committees. The generation and genotyping procedure
of Tph2−/− and Sert−/− animals were described previously
(Bengel et al., 1998; Gutknecht et al., 2008). Animals were housed
under a 12 h light/dark cycle (lights on: 08:00–20:00) at ambi-
ent temperature of 22 ± 1◦C and a relative humidity of 40–50%.
Data from Tph2 wt and Sert wt mice were treated together, since
both mouse lines were backcrossed more than 10 generations
into a C57BL/6J background and thus considered to have the
same genetic background. Data from male and female mice were
pooled.
DRUGS
SR-95531 (gabazine; GABAA receptor antagonist), D-AP5
(NMDA glutamate receptor antagonist), DNQX (AMPA/kainate
receptor antagonist) were purchased from Ascent Scientiﬁc Ltd
(Bristol, UK). N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-
N-2-pyridinylcyclohexanecarboxamide maleate (WAY-100635
maleate; selective 5-HT1A receptor antagonist), CGP-55845
hydrochloride (selective GABAB receptor antagonist), and R(+)-
8-hydroxy-2-(di-n-propylamino)tetralin (R(+)-8-OH-DPAT)were
purchased from Tocris Bioscience (Bristol, UK). Strychnine
(glycine receptor antagonist), Trp, 5-HTP, and L-phenylephrine
were obtained from Sigma-Aldrich S.r.l. (Milan, Italy).
Frontiers in Pharmacology | Neuropharmacology August 2013 | Volume 4 | Article 97 | 2
“fphar-04-00097” — 2013/8/1 — 15:40 — page 3 — #3
Araragi et al. Autoinhibition in 5-HT system-deﬁcient mice
ELECTROPHYSIOLOGICAL RECORDING
Methods used follow those reported previously (Gutknecht et al.,
2012). Mice (28–80 days old) were anesthetized with isoﬂu-
rane and decapitated. The brain was immediately removed,
dissected in ice-cold gassed (95% O2,5% CO2) artiﬁcial cere-
brospinal ﬂuid (ACSF) containing (in mM): 124 NaCl, 2.75
KCl, 1.25 NaH2PO4, 1.3 MgCl2, 2 CaCl2, 26 NaHCO3,
11 D-glucose (pH 7.4), and the brainstem was sliced coronally
into 200 μm thick slices with a vibratome (DSK-1000; Dosaka
Co. Ltd, Kyoto, Japan) and transferred to a multi-well incubation
chamber ﬁlled with bubbled ACSF at room temperature. After
at least 90 min of recovery, the slices were individually trans-
ferred into the recording chamber and superfused continuously
with gassed, warmed ACSF (34–35◦C) at a rate of 2 ml min−1.
Superfusing ACSF was supplemented with 10 μM phenylephrine
to facilitate ﬁring (Vandermaelen and Aghajanian, 1983) and with
a mixture of neurotransmitter blockers for glutamate, glycine,
and GABA receptors (in μM: 10 DNQX; 20 D-AP5; 10 strych-
nine; 1 CGP-55845; 10 SR-95531) to functionally isolate the
recorded neuron from synaptic input. Neurons were visualized
by infrared differential interference contrast video microscopy
with a Newicon C2400-07 camera (Hamamatsu,Hamamatsu City,
Japan) mounted to an Axioskop microscope (Zeiss, Göttingen,
Germany). Recordings were made using an EPC-10 ampliﬁer
(HEKA Elektronik, Lambrecht, Germany). Patch pipettes were
prepared from thick-walled borosilicate glass on a P-97 Brown-
Flaming electrode puller (Sutter Instruments, Novato, CA, USA)
and had resistance of 3–6 M when ﬁlled with solution con-
taining (in mM): 125 NaCl, 10 HEPES, 2.75 KCl, 2 CaCl2, 1.3
MgCl2 (pH 7.4 with NaOH). Loose-seal cell-attached record-
ings (5–20 M seal resistance) were acquired continuously in the
voltage-clamp mode. Signals were ﬁltered at 3 kHz and digitized
at 10 kHz. Pipette potential was maintained at 0 mV. Record-
ings were aborted if ﬁring rate was sensitive to changes in pipette
holding potential or if shapes of action current changed. Data
were analyzed using Clampﬁt 9.2 (Molecular Devices, Sunnyvale,
CA, USA).
Neurons with likely serotonergic speciﬁcation were ﬁrst
targeted according to morphological criteria (Brown et al., 2008):
5-HTneurons are clustered along themidline of theDRNand they
have a larger soma (∼20–25 μm long-axis diameter) than non-
serotonergic neurons (∼10–15μm). Once loose-seal cell-attached
recording conﬁguration was established, 5-HT neurons were iden-
tiﬁed according to electrophysiological criteria (Vandermaelen and
Aghajanian, 1983; Allers and Sharp, 2003). Neurons were consid-
ered serotonergic if, during at least 5 min-long baseline period at
the beginning of the recording displayed slow and steady ﬁring rate
(<5 Hz); asymmetric action current with long upstroke to down-
stroke interval (proportional to action potential half-height width,
>0.85 ms). According to these criteria, 250 out of 277 recorded
neurons were identiﬁed as being serotonergic. Pharmacological
experiments were done on 176 presumed serotonergic neurons,
whose identitywas pharmacologically conﬁrmedbasedon5-HT1A
receptor-mediated suppression of their ﬁring rate. For all groups
of neurons used in pharmacological experiments (Figures 2–4),
the basal ﬁring rate was matched and proved to be not different
after post hoc statistical analysis (Kruskal–Wallis test, p > 0.7).
Since experiments to assess autoinhibition depend on endogenous
5-HT, recordings were made from neurons located at least 50 μm
below the slice surface (Mlinar et al., 2005). A single experiment
was done in each slice.
For creating concentration–response curves for R(+)-8-OH-
DPAT and 5-HTP application, drugs were applied for 10 min and
mean ﬁring rates were calculated from the last 1-min segment
of each experimental epoch [e.g., baseline, R(+)-8-OH-DPAT
0.1 nM, 0.3 nM, etc.]. Trp was applied for 15 min and mean ﬁring
rates were obtained from the last 3-min segment of baseline and
Trp application.
STATISTICAL ANALYSIS
All the statistical tests were performed by GraphPad Prism version
5.04 (GraphPad Software, San Diego, CA, USA). First, normality
of data distribution was tested by D’Agostino–Pearson omnibus
normality test.When the datawere normally distributed, genotype
effects were tested by one-way ANOVA [expressed as F(df1,df2) val-
ues] followed by Tukey’s post hoc test. If not, data were analyzed
by Kruskal–Wallis test [expressed as H(df ) values] with Dunn’s
post hoc test. For testing effects of Trp in comparison to respective
baseline, data (%change in ﬁring rates)were analyzed byWilcoxon
signed rank test (two-tailed). In all cases, p < 0.05 was considered
statistically signiﬁcant.
RESULTS
COMPARISON OF BASAL FIRING RATES ACROSS GENOTYPES
In the absence of precursor supplementation (Trp or 5-HTP),
and in the presence of receptor blockers for glutamate, GABA,
and glycine receptors, the basal ﬁring of 5-HT neurons in slices
is relieved from the autoinhibitory control of endogenous 5-HT
(Mlinar et al., 2005) and local action of major neurotransmitters.
In these conditions of pharmacological isolation, the basal ﬁring
activity of 5-HT neurons reﬂects their intrinsic pacemaker activ-
ity, a characteristic that is difﬁcult to study in vivo, where the
ﬁring activity is under control of both autoinhibition and synaptic
input.
We compared the basal ﬁring rates recorded before 5-HT
precursor or 5-HT1A receptor agonist application, across geno-
types (Figure 1). Overall, 5-HT neurons showed typical regular
pacemaker activity and ﬁring rates similar to wt controls [in
Hz: Tph2−/−, 1.61 ± 0.82 (n = 54); Tph2+/−, 1.90 ± 0.66
(n = 45); wt, 1.97 ± 0.69 (n = 54); Sert+/−, 1.85 ± 0.74
(n = 47); Sert−/−, 2.12 ± 0.75 (n = 50); mean ± SD; n = num-
ber of recorded neurons], except for Tph2−/− in which the
ﬁring rate was slightly, but signiﬁcantly slower than in wt con-
trols (p < 0.05, Kruskal–Wallis test followed by Dunn’s multiple
comparison test). These data show that basic electrophysiological
properties underlying the typical pacemaker activity of 5-HT neu-
rons are maintained regardless of genetic inactivation of Tph2 or
Sert.
COMPARISON OF 5-HT1A RECEPTOR SENSITIVITY ACROSS GENOTYPES
Since 5-HT neuron autoinhibition is mediated by 5-HT1A recep-
tors, we investigated the functional response of 5-HT neurons to
the 5-HT1A receptor agonist R(+)-8-OH-DPAT in different geno-
types. Figure 2 illustrates typical experiments in which increasing
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FIGURE 1 | Comparison of 5-HT neuron basal firing rates across
genotypes. Data are shown as mean ± SD (number of cells shown in
parentheses). Analysis of data using Kruskal–Wallis test revealed
statistically signiﬁcant differences among groups [H(4) = 16.67, p = 0.002].
Dunn’s multiple comparison post hoc test resulted in being signiﬁcant for
Sert−/− vs.Tph2−/− (**p < 0.01) and wt vs.Tph2−/− (*p < 0.05).
concentrations of R(+)-8-OH-DPAT were applied in slices from
wt controls (Figures 2A,B), Tph2−/− (Figures 2C,D), and
Sert−/− mice (Figures 2E,F). Application of R(+)-8-OH-DPAT
reduced the ﬁring rate of 5-HT neurons in a concentration-
dependent manner, but with different effectiveness across geno-
types, as shown by the comparison of log EC50 values obtained
for each single neuron tested (log EC50 mean ± SD): Tph2−/−,
−8.82 ± 0.29 (n = 16); Tph2+/−, −8.52 ± 0.19 (n = 11); wt,
−8.52 ± 0.25 (n = 12); Sert+/−,−8.22 ± 0.27 (n = 11); Sert−/−,
−7.17 ± 0.42 (n = 8; Figure 2G). Differences across genotypes
were statistically signiﬁcant [F(4,53) = 48.38, p < 0.0001, one-way
ANOVA]. Compared to wt controls, the response to application of
R(+)-8-OH-DPAT resulted in slightly higher effectiveness of the
agonist in Tph2−/− mice (p < 0.05) and very weak effectiveness
in Sert−/− mice (p < 0.001). Although a small decrease in the
sensitivity of 5-HT neurons was present also in Sert+/− mice, no
statistically signiﬁcant differences in log EC50 values were found
for both Tph2+/− and Sert+/− vs. wt control mice, indicat-
ing that limited impairment of 5-HT synthesis and re-uptake did
not result in relevant changes of 5-HT1A autoreceptor sensitivity
to R(+)-8-OH-DPAT. Figure 2H shows concentration–response
curves ﬁtted for each group on mean data obtained from the indi-
vidual experiments shown in Figure 2G. It should be noted that
in Sert−/− neurons, R(+)-8-OH-DPAT did not produce maxi-
mal inhibition of ﬁring (see Figure 2E). Nevertheless, the average
maximal inhibition was 60% compared to the other genotypes
and the mean log value of concentrations producing an actual
50% decrease in ﬁring of Sert−/− neurons was −6.91 ± 0.08
(n = 8), which did not affect the level of signiﬁcance for decreased
sensitivity of 5-HT1A receptors shown in Figure 2G. Collectively,
these data show that the sensitivity of 5-HT1A receptors to agonist
activation is markedly affected in Sert−/−.
ESTIMATION OF AUTOINHIBITION EXERTED BY ENDOGENOUS 5-HT
ACROSS GENOTYPES
After assessing responsiveness to direct activation by the 5-HT1A
receptor agonist R(+)-8-OH-DPAT in the different genotypes, we
investigated how speciﬁc genetic alterations translate into inhibi-
tion of 5-HT neuron activity by endogenous 5-HT. Once synthesis
of 5-HT is restored in slices by supplementation of 5-HT precur-
sors, the extent of autoinhibition in the different genotypes will
depend on the balance between the level of extracellular 5-HT
determined by the alteration of homeostatic mechanisms intro-
duced by genetic manipulation and 5-HT1A receptor sensitivity
characteristic of each genotype.
Thus, we studied autoinhibition exerted by endogenous 5-HT,
when de novo synthesis was restored in slices by supplementa-
tion of Trp or 5-HTP. Trp was used to estimate the extent of
autoinhibition in respect to bioavailability of the natural precur-
sor (Mlinar et al., 2005). 5-HTP was used to bypass the constraint
in 5-HT synthesis produced by the rate-limiting enzyme Tph2.
This allows reaching extracellular 5-HT concentrations greater
than with Trp and permits quantiﬁcation of the overall capacity
of 5-HT neuron autoinhibition in different genotypes, including
Tph2−/− mice.
Figure 3A shows that supplementation of Trp (30 μM) pro-
duced a decrease in ﬁring rates of Sert−/− 5-HTneurons, an effect
fully antagonized by WAY-100635, a selective 5-HT1A receptor
neutral antagonist (Corradetti et al., 1998). This demonstrates that
5-HT1A receptor-mediated autoinhibition is present in Sert−/−
mice. As shown in Figure 3B, 30 μM Trp signiﬁcantly decreased
ﬁring rates of 5-HT neurons to a similar extent in all the geno-
types tested (in % ± SD): Tph2+/−, 25.62 ± 15.37 (n = 10);
wt, 25.55 ± 19.87 (n = 7); Sert+/−, 17.51 ± 12.99 (n = 11);
Sert−/−, 22.03 ± 17.00 (n = 14). In all cases, the decrease in ﬁr-
ing rates was signiﬁcantly different from zero (p < 0.05; Wilcoxon
signed rank test). Furthermore, responses to application of Trp
were not statistically different across four genotypes [H(3) = 3.336,
p = 0.3427; Kruskal–Wallis test]. These data show that autoinhi-
bition of DRN 5-HT neurons by endogenous 5-HT is conserved
in all the genotypes to a similar level, irrespective of the genetic
alteration.
To quantify the extent to which each genotype conserved
the capacity to (auto)inhibit 5-HT neuron ﬁring in response to
different extracellular concentrations of endogenous 5-HT, we
investigated the functional response of 5-HT neurons to 5-HTP in
different genotypes.
Figure 4 illustrates ﬁring rate changes of 5-HT neurons
in response to increasing concentrations of 5-HTP in brain
slices obtained from wt controls (Figures 4A,B), Tph2−/−
(Figures 4C,D), and Sert−/− mice (Figures 4E–H). Applica-
tion of 5-HTP reduced the ﬁring rate of 5-HT neurons in a
concentration-dependent manner, but with different effectiveness
across genotypes [one-way ANOVA, F(4,58) = 6.723, p = 0.0002],
as shown by the comparison of log EC50 values obtained for
each single neuron tested (log EC50 mean ± SD): Tph2−/−,
−5.51 ± 0.41 (n = 15); Tph2+/−, −5.29 ± 0.30 (n = 10);
wt, −5.17 ± 0.20 (n = 14); Sert+/−, −5.48 ± 0.36 (n = 13);
Sert−/−, −5.76 ± 0.12 (n = 11; Figure 4I). Interestingly,
the sensitivity to the effects of endogenous 5-HT synthesized
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FIGURE 2 | Sensitivity of 5-HT neurons to R(+)-8-OH-DPAT differs
across genotypes.Time courses of ﬁring rate changes in response to
increasing concentrations of R(+)-8-OH-DPAT of individual 5-HT neurons
in brain slices obtained from wt (A,B),Tph2−/− (C,D), and Sert−/− mice
(E,F). Traces show action current of corresponding neurons recorded.
(G) Dots represent log EC50 of concentration–responses from individual
experiments. Red lines report mean ± SD of values. One-way ANOVA
followed byTukey’s multiple comparison test showed statistically
signiﬁcant differences across genotypes [F (4,53) = 48.38, p < 0.0001].
Asterisks indicate level of statistical signiﬁcance between the indicated
genotypes (for Sert−/−, vs. all the other four genotypes): ***p < 0.001,
*p < 0.05. (H) Average concentration–response curves obtained from all the
experiments. Each data point corresponds to the mean from several neurons
(numbers in parentheses). For the sake of clarity, error bars are shown only
for Sert−/− mice andTph2−/− mice in a single direction. Data are normalized
on average baseline ﬁring rates recorded before R(+)-8-OH-DPAT application.
Note that, curves for Sert−/− mice did not achieve full inhibition of ﬁring
(see E).
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FIGURE 3 | Autoinhibition by endogenous 5-HT synthesized from
Trp is conserved across genotypes. (A)Trp (30 μM) produced a 5-HT1A
receptor-mediated decrease in the ﬁring rate of a 5-HT neuron from
Sert−/− mice. Application of a selective 5-HT1A receptor antagonist,
WAY-100635 (50 nM; representative of three experiments) fully antagonized
Trp effect, conﬁrming that autoinhibition was mediated by 5-HT1A
autoreceptors. (B) Application of 30 μMTrp signiﬁcantly suppressed ﬁring
activity of DRN serotonergic neurons in all the genotypes tested (p < 0.05;
Wilcoxon signed rank test). Comparison of the effect of Trp among
genotypes revealed no statistically signiﬁcant differences among
genotypes [H(3) = 3.336, p = 0.3427; Kruskal–Wallis test]. Data are shown
as mean ± SD. The number of neurons recorded for each genotype is
shown at the bottom of the histograms.
from 5-HTP was increased both in Tph2−/− (p < 0.05) and
Sert−/− (p < 0.001) mice compared to wt controls. Figure 4J
shows concentration–response curves ﬁtted for each group on
mean data obtained from the individual experiments depicted in
Figure 4I.
Whereas a stronger autoinhibitory response to 5-HTP in
Tph2−/− mice is consistent with the observed increase in sensi-
tivity of 5-HT1A receptors to agonist activation, a similar increase
in Sert−/− mice is unexpected in the presence of decreased
sensitivity to R(+)-8-OH-DPAT. We suggest that, due to the
absence of 5-HT re-uptake, in Sert−/− mice the extracellular
5-HT neosynthesized from 5-HTP attains higher levels than in
wt control mice, leading to this apparent increase in response.
Collectively, these results demonstrate that the changes in sensi-
tivity to direct activation of 5-HT1A receptors cannot directly be
translated into the expected changes in autoinhibition exerted by
endogenous 5-HT.
DISCUSSION
In the present study, we have investigated the relationship between
the sensitivity of 5-HT1A receptors and the concomitant degree
of autoinhibition of 5-HT neurons in a panel of genetically mod-
iﬁed mice characterized by impairment of cellular mechanisms
crucial for homeostatic control of extracellular 5-HT levels (i.e.,
5-HT synthesis and 5-HT re-uptake). In vivo, these genetic manip-
ulations are likely to produce lifelong persistent modiﬁcations
of 5-HT levels ranging from the absence of 5-HT in Tph2−/−
mice (Savelieva et al., 2008; Alenina et al., 2009; Gutknecht et al.,
2012) to a substantial increase in extracellular 5-HT levels in
Sert−/− mice (Fabre et al., 2000; Mathews et al., 2004; Shen et al.,
2004). The consequences of genetic alterations are maintained in
vitro. This provides a set of conditions in which the relationship
between the sensitivity of 5-HT1A receptors and the autoinhibitory
response of 5-HT neurons exerted by endogenous 5-HT could be
quantitatively compared.
The major ﬁnding of the present study is that substantial and
persistent alterations in 5-HT homeostasis produced changes in
the sensitivity of 5-HT1A receptors that did not translate in mea-
surable changes of autoinhibitory regulation of 5-HT neuron
ﬁring. In particular, Sert−/− mice showed a marked subsensi-
tivity of 5-HT1A receptors, but displayed a normal capacity of
autoinhibition. Interestingly, the sensitivity of 5-HT1A receptors
of both Sert+/− and Tph2+/− mice proved to be similar to
that of wt control mice, showing that mild change in extracel-
lular 5-HT levels is neither a strong stimulus for 5-HT1A receptor
adaptive changes in sensitivity, nor does it detectably affect
autoinhibition.
In previous studies under similar recording conditions as
used in this work, raphe slices showed substantial depletion
of 5-HT in the absence of 5-HT precursors (Liu et al., 2005;
Mlinar et al., 2005). In vitro, 5-HT content, together with
5-HT1A receptor-mediated autoinhibition, can be restored by
supplementation of Trp (Liu et al., 2005; Mlinar et al., 2005;
Evans et al., 2008; Gutknecht et al., 2012). This allowed elec-
trophysiological, quantitative, assessment of the modiﬁcations
in sensitivity of 5-HT1A receptors produced by altered 5-HT
homeostasis in vivo and estimation of the functional state of
autoinhibition when de novo synthesis of 5-HT was restored in
slices.
GENETIC MANIPULATIONS DO NOT AFFECT PACEMAKER
CHARACTERISTICS OF 5-HT NEURONS
The pacemaker properties of serotonergic neurons measured in
slices in the virtual absence of endogenous 5-HT neosynthesis,
hence of autoinhibition, were not substantially altered by genetic
manipulation itself, as we observed similar baseline ﬁring rates
among genotypes, except for Tph2−/− mice, which had slightly
lower baseline ﬁring rates compared to the other genotypes. This
shows that the basic characteristics of intrinsic pacemaker ﬁr-
ing activity of 5-HT neurons are preserved independently from
genetic manipulations that altered 5-HT homeostatic regulation.
The small decrease in baseline ﬁring rates observed in Tph2−/−
mice may indicate that, in the chronic absence of 5-HT, neurons
adapt their membrane properties, e.g., conductance, to compen-
sate for absent autoinhibition andhomeostatically keeppacemaker
ﬁring activity constant. The mechanism(s) underlying this adap-
tation is currently under investigation. It should be noted that the
basal ﬁring rate recorded under our experimental conditions, i.e.,
in vitro, results from the interplay of ion conductances responsible
for pacemaking activity and likely do not correspond to the“basal”
ﬁring rate recorded in vivo (e.g., Gobbi et al., 2001; Bouali et al.,
2003; see below) which is under the control of 5-HT1A receptor-
mediated autoinhibition in all genotypes (see Figure 3), except in
Tph2−/− mice (Gutknecht et al., 2012).
LIFELONG EXPOSURE OF 5-HT NEURONS TO VARYING 5-HT LEVELS
RESULTS IN CHANGES IN THE SENSITIVITY OF SOMATODENDRITIC
5-HT1A RECEPTORS
Previous studies showed adaptive decrease in sensitivity of 5-HT1A
receptors in Sert−/− mice (Lanfumey et al., 2000; Mannoury
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FIGURE 4 | Quantification of autoinhibition capacity of 5-HT
neurons across genotypes by concentration–response curves
for 5-HTP.Time courses of 5-HT neuron ﬁring rate changes in response
to increasing concentrations of 5-HTP in brain slices obtained from wt
controls (A,B),Tph2−/− (C,D), and Sert−/− mice (E–H). Traces show action
current of corresponding neurons recorded. (I) Dots represent log EC50 of
concentration–responses from individual experiments. Red lines report
mean ± SD of values. One-way ANOVA followed byTukey’s multiple
comparison test showed statistically signiﬁcant differences [F (4,58) = 6.723,
p = 0.0002] Asterisks indicate level of statistical signiﬁcance between the
indicated genotypes: ***p < 0.001, **p < 0.01, *p < 0.05. (J) Average
concentration–response curves obtained from all the experiments. Each data
point corresponds to the mean from several neurons (numbers shown in
parentheses). For the sake of clarity, error bars are omitted. Data are
normalized on average baseline ﬁring rates recorded before 5-HTP
application.
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la Cour et al., 2001; Bouali et al., 2003). Our study extends the
investigation to the opposite extreme, i.e., Tph2−/− mice, which
are devoid of 5-HT and show a small, but signiﬁcant increase in
5-HT1A receptor sensitivity. This is consistent with neurochemical
data showing an increase in 5-HT1A receptor density in the raphe
(Gutknecht et al., 2012).
In Sert−/− mice, we found a decrease in the maximal response
to R(+)-8-OH-DPAT (∼40%) and a similar reduction of autoin-
hibitory capacity as revealed by concentration–response curves
with 5-HTP. This may reﬂect a downregulation of 5-HT1A recep-
tors due to lifelong exposure to increased stimulation by 5-HT or
the emergence of a still-unknown adaptive mechanism directed
to counteract increased autoinhibition exerted by high levels
of extracellular 5-HT in vivo. In spite of the decrease, how-
ever, the remaining autoinhibition capacity of 5-HT neurons
largely exceeded the magnitude of physiological autoinhibition
produced by 5-HT when its synthesis was restored by Trp
(see below).
Taken together, our data indicate that the level of 5-HT1A
receptor sensitivity of 5-HT neurons is inversely correlated with
extracellular levels of 5-HT in vivo, at least in extreme conditions
as represented by Tph2−/− and Sert−/− mice.
AUTOINHIBITION OF 5-HT NEURONS BY ENDOGENOUS 5-HT IS
CONSERVED IN THE PHYSIOLOGICAL RANGE, REGARDLESS OF THE
SENSITIVITY OF 5-HT1A RECEPTORS
When the level of autoinhibition restored by Trp supplemen-
tation in slices from all the genotypes (except Tph2−/−) was
measured, this resulted in being similar, irrespective of the sen-
sitivity of 5-HT1A receptors measured in each genotype. Notably,
Sert−/− showed greatly decreased sensitivity to the agonist but
normal autoinhibition, as estimated by Trp challenge. Accord-
ingly, the autoinhibitory effect of endogenous 5-HT synthesized
de novo from 5-HTP proved to be not decreased in all the
mutants compared with wt controls, including Tph2−/− in
which the absence of Tph2 was bypassed by 5-HTP. It should
be noted that in Sert−/− mice the maximal inhibitory response
was slightly decreased (∼20%) in agreement with the reduced
maximal response to the agonist, but the substantial residual
inhibition capacity is apparently sufﬁcient to produce a phys-
iological level of autoinhibition as shown by Trp experiments.
In conclusion, these data indicate that the marked subsen-
sitivity of 5-HT1A receptors observed in Sert−/− does not
translate in the loss of normal autoinhibition capacity of 5-HT
neurons.
Although counterintuitive, this notion is consistent with the
observation that, in vivo, the ﬁring rate of 5-HT neurons is not
increased in Sert−/−, but similar to or even lower (Gobbi et al.,
2001; Bouali et al., 2003) than that of wt controls, thus indicating
that in vivo subsensitivity of 5-HT1A receptors in Sert−/− mice
does not relieve 5-HT neurons from autoinhibition. Furthermore,
Fox et al. (2010) reported that in thesemice antagonismof 5-HT1A
receptors by WAY-100635 resulted in the appearance of greater
frequency of 5-HT2A receptor-mediated head twitches than in wt
controls. This suggests that the relief from autoinhibition, hence
the increase in 5-HT neuron ﬁring, produces an increase in 5-
HT release sufﬁcient to produce this 5-HT2A-mediated behavioral
effect (Willins and Meltzer, 1997), even in the presence of partial
desensitization of 5-HT2A receptors (Rioux et al., 1999; Li et al.,
2003; Qu et al., 2005).
IMPLICATIONS OF THE DIVERGENCE BETWEEN SENSITIVITY TO
R(+)-8-OH-DPAT AND 5-HT NEURON AUTOINHIBITION
The crucial role of somatodendritic 5-HT1A receptors in regulat-
ing the ﬁring rate of 5-HT neurons, hence the functional state
of 5-HT system, has attracted interest in the attempt to infer
the degree of activity of these neurons in pathological condi-
tions of humans and in behavioral experiments of rodents. The
present work may help to better understand the limits in the
interpretation of the functional state of 5-HT system based on
measurements of density/sensitivity of 5-HT1A receptors of 5-HT
neurons. Furthermore, since the knockout mice used in this inves-
tigation may model different risk factors (i.e., TPH2 and SERT
polymorphisms) for anxiety disorders and depression, our data
showing that autoinhibition is not impaired in these mutants
may provide a reference background for the interpretation of
behavioral responses in these mice in the context of human psy-
chopathology. For instance, functional autoinhibition in patients
with depression were indirectly inferred from 5-HT1A receptor
imaging studies in the raphe (Drevets et al., 2007; Savitz et al.,
2009). Overall, however, these studies failed to clarify whether
the depression-related changes in 5-HT1A receptor binding are
genetically or environmentally driven during development, thus
causative of the disorder, or whether they are simply an adapta-
tion to acutely increased or decreased serotonergic transmission
(Savitz et al., 2009).
Contradicting results were also gathered in the attempt to asso-
ciate SERT polymorphisms with changes in the level of 5-HT1A
receptor expression/density. David et al. (2005) reported that car-
riers of the 5-HTTLPR s-allele had lower 5-HT1A receptor binding
potential in all the brain regions investigated compared to indi-
viduals homozygous for the l-allele. On the contrary, Lee et al.
(2005) found that s-carriers had higher 5-HT1A binding than ll-
individuals in pregenual and subgenual cingulate cortex regions
while in other regions, including the DRN, no difference was
detected. More recently, Borg et al. (2009) could not reveal any
differences in 5-HT1A receptor density between carriers and non-
carriers of the 5-HTTLPR s-allele and concluded that functional
consequences of 5-HTTLPR are not likely to bemediated by differ-
ences in 5-HT1A expression. Our results showing that 5-HT system
autoinhibition is not reduced in mice with impaired Sert function
even in the presence of altered 5-HT1A receptor sensitivity would
support this conclusion.
A second implication of our results involves the possibility to
infer the degree of 5-HT system autoinhibition from functional
assays using activation of 5-HT1A receptors with direct agonists,
in patients or in animal models. For example, one of the most
consistent ﬁndings among depressed patients is their blunted
hypothermia in response to 5-HT1A receptor direct agonists (Lesch
et al., 1990; Lesch, 1991; Jacobsen et al., 2012b and references
therein). Such responses are usually ascribed to desensitization
of somatodendritic 5-HT1A receptors (reviewed in Jacobsen et al.,
2012a). Our data suggest that, whereas blunted hypothermic
response to direct agonists is likely to reﬂect subsensitivity of
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5-HT1A receptors in these patients, this decrease in response
cannot directly be correlated to functional consequences that entail
reduced autoinhibition and increase in the basal ﬁring rate of 5-HT
neurons.
On the other hand, the ﬁnding that 5-HT neurons in Tph2-
and Sert-deﬁcient mice display normal responsiveness to Trp
and/or 5-HTP regarding autoinhibition of 5-HT neuron ﬁring
would support the use of Trp (or 5-HTP) as an appropriate
challenge to test the functional state of 5-HT system in clinical
settings and to reveal the involvement of altered autoinhibition in
human psychopathology. Indeed, 5-HTP challenge has been suc-
cessfully applied to reveal functional consequences dependent on
5-HTTLPR variation in humans (Maron et al., 2004).
Finally, the striking divergence between sensitivity to R(+)-8-
OH-DPAT and 5-HT neuron autoinhibition in Sert−/− suggests
the possibility that sustained increase in 5-HT levels by stressors
or pharmacological treatments (e.g., SSRIs) may result in 5-HT1A
receptor subsensitivity, not accompanied by functional impair-
ment of 5-HT neuron ﬁring autoregulation. For instance, the
rapid decrease in 5-HT1A receptor sensitivity found in DRN 5-HT
neurons following chronic ultramild stress and stressful uncon-
trolled environmental conditions is apparently not correlated with
an increase in 5-HT system activity and has been suggested to be
an adaptive mechanism to compensate for 5-HT ﬂuctuations pro-
ducedby stressful events (Laaris et al., 1999; Lanfumey et al., 1999).
Interestingly, in vivo recording after chronic unpredictable stress
in rats showed that the reduced ability of 8-OH-DPAT to inhibit
5-HTneuron ﬁringwas accompanied by a decrease in ﬁring rate of
DRN 5-HT neurons (Bambico et al., 2009), indicating that func-
tional autoinhibitionmay be preserved in spite of 5-HT1A receptor
desensitization. Furthermore, desensitization of autoinhibitory 5-
HT1A receptors occurring with chronic SSRI administration (Le
Poul et al., 2000; Hensler, 2002; Castro et al., 2003) has been pro-
posed as a mechanism for 5-HT neurons to escape the sustained
autoinhibition produced by the increase in 5-HT in raphe nuclei
by blockade of Sert and to represent an important step to achieve
enhanced therapeutic effects of SSRIs (Artigas et al., 1996). On the
other hand, Richardson-Jones et al. (2010) showed that desensiti-
zationof 5-HT1A autoreceptors is not sufﬁcient for antidepressants
to convey their efﬁcacy, indicating dissociation between desensiti-
zation of 5-HT1A autoreceptors and behavioral effects of chronic
SSRI treatment. Thus, desensitization of 5-HT1A autoreceptors
appears rather to be an adaptive mechanism to neutralize ele-
vated extracellular 5-HT levels, and not a primary factor leading
to behavioral alteration.
Under a functional perspective, however, dynamic changes
in the sensitivity/expression of 5-HT1A receptors appear to be
crucial to fulﬁll the requirements for physiological homeosta-
sis of 5-HT system functioning. Thus, any impairment of
adaptive mechanisms of 5-HT1A receptors in response to sus-
tained changes in 5-HT levels, or constitutive alteration of
their expression even in the absence of altered 5-HT levels in
vivo, becomes a potential source of pathological consequences.
In fact, genetically induced overexpression of somatodendritic
5-HT1A receptors in mice has been shown to produce auto-
nomic dysregulation (Audero et al., 2008), behavioral alterations,
and decreased response to antidepressant drugs (Richardson-
Jones et al., 2010). In humans, the C(-1019)G 5-HT1A promoter
polymorphism leading to 5-HT1A receptor overexpression is
proposed to represent a risk factor for depression (Lemonde
et al., 2003; Strobel et al., 2003; Rothe et al., 2004; reviewed in
Albert and Francois, 2010) and response to antidepressant drugs
(reviewed in Albert, 2012).
In conclusion, our data reveal that 5-HT neuron autoinhibition
is similar in all Tph2 and Sert genotypes studied, regardless of the
different sensitivity of their somatodendritic 5-HT1A receptors to
R(+)-8-OH-DPAT. This suggests that adaptive changes in recep-
tor sensitivity occur to compensate for variable extracellular 5-HT
levels in different genotypes to homeostatically conserve autoin-
hibition in a physiological range. Thus, it appears that response to
5-HT1A agonists per se is not always sufﬁcient for evaluating the
functional state of the 5-HT system, for which Trp and/or 5-HTP
challenges may provide more informative data, both in clinical
and animal experimental settings.
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